A carregar...
Publicação
The impact of research and development intensity on Ebitda multiples in the healthcare industry in North America - a focus on the healthcare equipment and supply Sector sub-sector
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 6.34 MB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
This study investigates the relationship between R&D intensity and company valuations in the
North American healthcare industry, using EBITDA multiples as a valuation metric. Through
a multiple regression analysis, the research reveals a significant positive correlation between
R&D intensity and company valuations, particularly in the sub-sector healthcare
pharmaceuticals, biotechnology, and life sciences, which has been investigated next to the
healthcare equipment and supplies sub-industry. The findings emphasize the role of R&D in
company valuations, contributing valuable insights to M&A decision-making processes within
the healthcare sector.
Descrição
Palavras-chave
Healthcare North America R&D intensity Ebitda multiples Equipment and supply